NCT07406191

WB-EMS Effects on Cardiometabolic Risk Factors

Recruiting now NA Last updated 14 April 2026

What this trial tests

NA trial testing WB-EMS in Hypertension in 42 participants. Currently enrolling.

Timeline

15 February 2026

Primary endpoint
30 November 2027

31 December 2027

Quick facts

Lead sponsor	University of Erlangen-Nürnberg Medical School
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	42
Start date	15 February 2026
Primary completion	30 November 2027
Estimated completion	31 December 2027
Sites	2 locations across Germany

Drugs / interventions tested

• WB-EMS
• Control

Conditions studied

• Hypertension — all drugs for Hypertension →
• Metabolic Syndrome — all drugs for Metabolic Syndrome →
• Hypercholesterolemia — all drugs for Hypercholesterolemia →
• Hypertriglyceridemia — all drugs for Hypertriglyceridemia →

Sponsor

University of Erlangen-Nürnberg Medical School

Who can join

Adults 50 to 70, male only, with Hypertension or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

From the age of 50 onwards, there is a disproportionate decline in muscle strength, mass and function, which can be prevented or at least delayed by physical training. Unfortunately, many training programmes are very time-consuming and strenuous and are therefore not carried out consistently. Whole-body electromyostimulation (WB-EMS), a technology in which all major muscle groups are stimulated with an adjusted stimulation level, could be a time-effective and joint-friendly alternative.

However, there are some contraindications to the widespread use of this technology, which are particularly common in middle-aged and elderly people. For example, high blood pressure, which affects more than half of men over the age of 50 in Germany, is considered a contraindication for WB-EMS training. However, this assessment is not very reliable; at least, acute WB-EMS application does not lead to an increase in blood pressure. In addition, there are no study results available for long-term WB-EMS application in people with high blood pressure.

The present study particularly investigate whether and to what extent several weeks of WB-EMS training has an effect on resting blood pressure in people with mild blood pressure. Additionally, the effect of WB-EMS on other cardiometabolic risk factors and physical function will be addressed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.